The potential benefits of 1.5% hetastarch as a cardioplegia additive

James A. Coles, Daniel C. Sigg, Paul A. Iaizzo

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'The potential benefits of 1.5% hetastarch as a cardioplegia additive'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds